Elevation of Serum PARK7 and IL-8 Levels Is Associated With Acute Lung Injury in Patients With Severe Sepsis/Septic Shock

Abstract

Objective:

Methods containing only clinical information fail to meet the needs of prediction of acute lung injury (ALI) because of the relatively low positive predictive value. This study aimed to investigate the feasibility of using biomarkers as predictors of ALI in populations with severe sepsis/septic shock and to explore difference among biomarkers after adjustment for potential confounders.

Methods:

Serum specimens were collected from patients with severe sepsis/septic shock (n = 172) presented to the emergency department. Patients should be ruled out from the study if they were already suffering from ALI or if they deteriorated into ALI within 6 hours after specimen collection. The development of ALI of the remaining patients was tracked.

Results:

Of all patients with severe sepsis/septic shock who encountered ALI more than 6 hours succeeding to specimen collection, 19 deteriorated into ALI. Elevation in serum interleukin 8 (IL-8) and Parkinson disease 7 (PARK7) levels had significant connection with higher risk of developing ALI (P = .006; P = .0001). Sepsis treatment and vasopressor application led to a robust connection between PARK7 and succeeding ALI development. Patients who deteriorated into ALI were distinguished accurately from patients who avoided ALI using PARK7 or Lung Injury Prediction Score (LIPS; area under the receiver operating characteristic curve [AUROC], 0.73 and 0.72 for each). Combination of PARK7 and LIPS ameliorated AUROC to 0.86 (vs 0.73, P = .05). On the contrary, serum soluble receptor for advanced glycation end products and von Willebrand factor made no contribution to the prediction of ALI development.

Conclusions:

Patients with PARK7 or IL-8 levels above normal are more vulnerable to ALI. Patients vulnerable to ALI can be distinguished with the combination of serum biomarkers and clinical prediction scores. In addition, the early rise in PARK7 emphasizes the importance of endothelial injury in the early pathogenesis of ALI.

Keywords

Parkinson disease 7 acute lung injury severe sepsis interleukin 8

Get full access to this article

View all access options for this article.

References

Brower

Lanken

MacIntyre

, et al. Blood institute, higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327–336.

Meade

Cook

Guyatt

, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):637–645.

Mercat

Richard

Vielle

, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):646–655.

National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay

Brower

Carson

, et al. Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med. 2011;184(5):561–568.

Levitt

Matthay

. Clinical review: early treatment of acute lung injury—paradigm shift toward prevention and treatment prior to respiratory failure. Crit Care. 2012;16(3):223.

Gajic

Dabbagh

Park

, et al. Lung injury prevention study, early identification of patients at risk of acute lung injury: evaluation of Lung Injury Prediction Score in a multicenter cohort study. Am J Respir Crit Care Med. 2011;183(4):462–470.

Kor

Warner

Alsara

, et al. Derivation and diagnostic accuracy of the surgical lung injury prediction model. Anesthesiology. 2011;115(1):117–128.

Trillo-Alvarez

Cartin-Ceba

Kor

, et al. Acute Lung Injury Prediction Score: derivation and validation in a population-based sample. Eur Respir J. 2011;37(3):604–609.

Calfee

Ware

Glidden

, et al. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med. 2011;39(4):711–717.

10.

Ware

Koyama

Billheimer

, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest. 2010;137(2):288–296.

11.

Nagakubo

Taira

Kitaura

, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun. 1997;231(2):509–513.

12.

Bonifati

Rizzu

van Baren

, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299(5604):256–259.

13.

Ariga

Takahashi-Niki

Kato

Maita

Niki

Iguchi-Ariga

. Neuroprotective function of DJ-1 in Parkinson’s disease. Oxid Med Cell Longev. 2013;2013:683920.

14.

Kahle

Waak

Gasser

. DJ-1 and prevention of oxidative stress in Parkinson’s disease and other age-related disorders. Free Radic Biol Med. 2009;47(10):1354–1361.

15.

Wilson

. The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal. 2011;15(1):111–122.

16.

Yamane

Murao

Kozuka

, et al. Serum DJ-1 level is positively associated with improvements in some aspects of metabolic syndrome in Japanese women through lifestyle intervention. Nutr Res. 2014;34(10):851–855.

17.

Allard

Burkhard

Lescuyer

, et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem. 2005;51(11):2043–2051.

18.

Cepkova

Brady

Sapru

Matthay

Church

. Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury. Crit Care. 2006;10(5):R126.

19.

Fremont

Koyama

Calfee

, et al. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma. 2010;68(5):1121–1127.

20.

McClintock

Zhuo

Wickersham

Matthay

Ware

. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care. 2008;12(2):R41.

21.

Parsons

Eisner

Thompson

, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33(1):1–6; discussion 230-232.

22.

Barnett

Ware

. Biomarkers in acute lung injury—marking forward progress. Crit Care Clin. 2011;27(3):661–683.

23.

Ware

Conner

Matthay

. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med. 2001;29(12):2325–2331.

24.

Ware

Eisner

Thompson

Parsons

Matthay

. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med. 2004;170(7):766–772.

25.

Uchida

Shirasawa

Ware

, et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med. 2006;173(9):1008–1015.

26.

Calfee

Budev

Matthay

, et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transplant. 2007;26(7):675–680.

27.

Rubin

Wiener-Kronish

Murray

, et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest. 1990;86(2):474–480.

28.

Liu

Chen

Shi

, et al. Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children. Crit Care. 2012;16(3):R91.

29.

Bernard

Artigas

Brigham

, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 pt 1):818–824.

30.

Force

ADT

Ranieri

Rubenfeld

, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533.

31.

Pencina

D’Agostino

Sr D’Agostino

Jr Vasan

. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172; discussion 207-212.

32.

Amatullah

Shan

Beauchamp

, et al. DJ-1/PARK7 impairs bacterial clearance in sepsis. Am J Respir Crit Care Med. 2017;195(7):889–905.

33.

Rainer

Lam

Wong

Cocks

. Derivation of a prediction rule for post-traumatic acute lung injury. Resuscitation. 1999;42(3):187–196.

34.

Liu

Chen

Wen

Kong

Gao

. PARK7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis. Cell Res. 2015;25(6):691–706.